GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Capex-to-Revenue

Zentek (TSXV:ZEN) Capex-to-Revenue : 0.00 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zentek Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Zentek's Capital Expenditure for the three months ended in Dec. 2024 was C$0.00 Mil. Its Revenue for the three months ended in Dec. 2024 was C$0.04 Mil.

Hence, Zentek's Capex-to-Revenue for the three months ended in Dec. 2024 was 0.00.


Zentek Capex-to-Revenue Historical Data

The historical data trend for Zentek's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek Capex-to-Revenue Chart

Zentek Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 11.72 31.14 10.67

Zentek Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.08 2.17 - - -

Competitive Comparison of Zentek's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Zentek's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentek's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zentek's Capex-to-Revenue falls into.


;
;

Zentek Capex-to-Revenue Calculation

Zentek's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.32) / 0.03
=10.67

Zentek's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.038
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zentek  (TSXV:ZEN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Zentek Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zentek's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentek Business Description

Traded in Other Exchanges
Address
24 Corporate Court, Guelph, ON, CAN, N1G 5G5
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Executives
Colin Stuart Van Der Kuur Senior Officer
Francis Jacques Dubé Director
Ilse Treurnicht Director
John Snisarenko Director
Brian Gerald Bosse Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Gregory Fenton Director
Eric Wallman Director

Zentek Headlines

From GuruFocus

SHAREHOLDER ALERT: Weiss Law Investigates Zendesk, Inc.

By PRNewswire PRNewswire 07-14-2022

WESTFIELD CAPITAL MANAGEMENT CO LP Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-14-2022

Top 5 4th Quarter Trades of HARVEST MANAGEMENT LLC

By GuruFocus Research GuruFocus Editor 02-18-2023

Top 5 2nd Quarter Trades of Sylebra Capital Ltd

By GuruFocus Research GuruFocus Editor 08-17-2022

Top 5 4th Quarter Trades of TOKIO MARINE ASSET MANAGEMENT CO LTD

By GuruFocus Research GuruFocus Editor 01-26-2023